Retrospective analysis of pts treated with cetuximab or panitumumab at an Italian and a Swiss cancer center.Primary or secondary endpoints were not defined.PCR amplification with specific primers followed by automated sequencing by ABIPRISM 3730 (Applied Biosystems, Foster City, CA) was used to identify KRAS and BRAF sequence variants. The gene discussed is KRAS; the disease is cancer.